ArticleLife (Basel, Switzerland)2025
The Role of Artificial Intelligence in Predicting the Progression of Intraocular Hypertension to Glaucoma.
Article in Life (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Augmented Decisions: AI-Enhanced Accuracy in Glaucoma Diagnosis and Treatment.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
AI systems, especially artificial neural networks (ANNs), are increasingly involved in the diagnosis and personalized management of ophthalmologic disorders.
backgroundThis study shows the practical applications of artificial intelligence for predicting the progression of intraocular hypertension (IOH) to glaucoma.
methodsThis study involved two groups of patients with IOH and a control group, analyzed using the commercial Neurosolution simulator. The findings were compared with experimental data. The performance of the neural models was evaluated using several metrics: Mean Squared Error (MSE), Normalized Mean Squared Error (NMSE), correlation coefficient (r
resultsFor all three patient groups, the best performance was achieved with neural networks featuring two hidden layers: MLP(9:18:9:3) for group 1, MLP(10:20:10:3) for group 2, and MLP(10:30:20:3) for group 3. The MSE values during validation were 0.39 for groups 1 and 2, and 0.34 for group 3. For these neural networks, the probability of producing correct outputs during validation was 75% (i.e., 9 correct responses out of a possible 12). The findings in this study are in line with those reported by other researchers in the field.
conclusionsThe neural network models developed in this study demonstrated their potential for predicting the progression of intraocular hypertension to glaucoma.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.